Elevated levels of NETs, myeloperoxidase (MPO), and neutrophils have been observed in the pulmonary vessels of patients with COVID-19 [84], suggesting that targeting NETs may offer therapeutic potential. This evidence concerns the gene MPO and COVID-19.